Kim Slocum, KDS Consulting, LLC
Advertisement
Articles by Kim Slocum, KDS Consulting, LLC
Advertisement
Latest Updated Articles
- The downside of pricing specialty pharmaceuticals too high
Published: May 1st 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The Longer-Term Impact of MFN Pricing
3
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
4
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
5
